Chang-Jiun Wu

12PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 28, 2024
Differential Characteristics on TCR Embedding Landscape Among Immune Checkpoint Blockade Responders Versus Non-Responders Against Non-Small Cell Lung Carcinoma.

Peiling Tsou, Chang-Jiun Wu

|Jan 10, 2024
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells.

Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang

|Sep 28, 2023
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.

Wen-Hao Hsu, Kyle A LaBella, Yiyun Lin

|Jun 21, 2023
Histone demethylase KDM5D upregulation drives sex differences in colon cancer.

Jiexi Li, Zhengdao Lan, Wenting Liao

|Dec 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.

Pat Gulhati, Aislyn Schalck, Shan Jiang

|Jul 09, 2022
Multi-modal molecular programs regulate melanoma cell state.

Miles C Andrews, Junna Oba, Chang-Jiun Wu

Pageof 2

Frequent Collaborators

6 joint publications

Ronald A DePinho

6 joint publications

Denise J Spring

3 joint publications

Kyle A LaBella

3 joint publications

Jun Li